T. Rowe Price Associates’s X4 Pharmaceuticals XFOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-83,015
| Closed | -$20K | – | 3158 |
|
|
2025
Q1 | $20K | Buy |
83,015
+27,019
| +48% | +$6.51K | ﹤0.01% | 3003 |
|
|
2024
Q4 | $41K | Hold |
55,996
| – | – | ﹤0.01% | 2953 |
|
|
2024
Q3 | $38K | Buy |
55,996
+5,770
| +11% | +$3.92K | ﹤0.01% | 2959 |
|
|
2024
Q2 | $30K | Buy |
50,226
+10,919
| +28% | +$6.52K | ﹤0.01% | 2896 |
|
|
2024
Q1 | $55K | Buy |
39,307
+12,514
| +47% | +$17.5K | ﹤0.01% | 2862 |
|
|
2023
Q4 | $23K | Hold |
26,793
| – | – | ﹤0.01% | 2865 |
|
|
2023
Q3 | $30K | Buy |
26,793
+1,788
| +7% | +$2K | ﹤0.01% | 2827 |
|
|
2023
Q2 | $49K | Buy |
+25,005
| New | +$49K | ﹤0.01% | 2799 |
|
|
2020
Q2 | – | Sell |
-153,202
| Closed | -$1.53M | – | 2540 |
|
|
2020
Q1 | $1.53M | Buy |
+153,202
| New | +$1.53M | ﹤0.01% | 1566 |
|